|
595 Concern
over revalidation ideas in regulation reports Concerns over a potential conflict of interest if employers play a significant role in the revalidation of pharmacists are raised by several bodies responding to the reports “The regulation of the non-medical healthcare professions” and “Good doctors, safer patients”, consultation on which ended last week
PJ 2006;277:595
Full Text
595 Community
pharmacists could be in line for access to NHS mail Community
pharmacists in England could be given access to NHS mail, the secure
national e-mail and directory service
PJ 2006;277:595
Full Text
595 Lloydspharmacy ordered
to pay compensation after steroid error Lloydspharmacy is waiting
to find out how much compensation it will have to pay a US lawyer after being
found liable for the ill-health she suffered from an excessive dose of dexamethasone
PJ 2006;277:595
Full Text
596 Contract
test words altered Changed wording for the control-of-entry test for
new pharmacy contracts in England and Wales does not mean there will be any change
to the criteria that primary care trusts and health boards will apply, the Department
of Health has said
PJ 2006;277:596
Full Text
596 Call for education
to counter drug promotion US campaigners against drug advertising
have published four objectives that they say should be built into
the education of all health professionals
PJ 2006;277:596
Full Text
596 Medicines in gift
bags illegal Goodie-bags handed to guests at a pharmacy awards dinner
last month were illegal because they contained free samples of medicines, including
prescription-only packs of Goldshield-brand ranitidine 150mg tablets. Other samples
contained in the gift bags included Bristol Laboratories paracetamol tablets
and ibuprofen tablets
PJ 2006;277:596
Full Text
596 Pfizer answers customers Pfizer
has this week sent a letter to pharmacists and dispensing doctors addressing
various questions raised by customers about the company's distribution arrangements
with UniChem
PJ 2006;277:596
Full Text
596 Contract favours multiples The
NHS pharmacy contract favours large pharmacy chains rather than small independent
businesses, according to Verdict Research
PJ 2006;277:596
Full Text
596 Enhanced services
packages Comprehensive packages for four “ready made” enhanced services have been developed by the Co-operative Pharmacy Group. The packages — for substance misuse, smoking cessation, minor ailments and emergency hormonal contraception services — also include prices
PJ 2006;277:596
Full Text
597 Community
matrons “will not reduce admissions” Community matrons
are unlikely to reduce hospital admissions, but will be popular with patients,
a review of similar case management systems published
PJ 2006;277:597
Full Text
597 Pharmacy care programme
cuts blood pressure in over-65s A pharmacy care programme can lead
to better adherence to medication and improvements in blood pressure and cholesterol
measures for patients over the age of 65 years, a study published online this
week suggests
PJ 2006;277:597
Full Text
597 Far wider population
would benefit from statin treatment Lifetime statin treatment would
be cost effective in a far wider population than that covered by current guidelines,
a study published
PJ 2006;277:597
Full Text
598 New
analysis suggests all SSRIs pose risks to young Young people taking
antidepressants are at increased risk from self-harm or suicidal behaviour, according
to a new analysis that supports previous studies
PJ 2006;277:598
Full Text
598 SSRIs’ effect
on depression apparent within first week Treatment with a selective
serotonin reuptake inhibitor (SSRI) is associated with symptomatic improvement
in depression by the end of the first week, according to a meta-analysis published
PJ 2006;277:598
Full Text
598 Depression link to
mortality in heart failure Depression, but not antidepressant use,
is associated with increased mortality in patients with heart failure, a prospective
study has indicated
PJ 2006;277:598
Full Text
598 Boundary-breaking
pharmacy wins UniChem award Regent Pharmacy, in Shanklin, Isle of
Wight, is this year's overall winner in the annual UniChem Pharmacy Awards (previously
the UniChem Great Business Awards)
PJ 2006;277:598
Full Text
598 NHS modernisation
continues The Queen's speech this week promised to “carry through the modernisation of health care based on the founding principles of the NHS”
PJ 2006;277:598
Full Text
599 Similar
CV risk for etoricoxib and diclofenac shown Risk of heart attack, death or stroke in arthritis patients treated with the cyclo-oxygenase-2 (COX-2) inhibitor etoricoxib is not statistically different from that in patients treated with the traditional non-steroidal anti-inflammatory drug (NSAID) diclofenac
PJ 2006;277:599
Full Text
599 Pioglitazone treatment
shows promise for atherosclerosis in diabetes People with type 2 diabetes
treated with pioglitazone have slower progression of a particular marker for
coronary atherosclerosis than those taking glimepiride, according to a study
released online
PJ 2006;277:599
Full Text
599 Erdosteine launched
in the UK for chronic bronchitis relief A new drug for the symptomatic treatment of acute exacerbations of chronic bronchitis — a form of chronic obstructive pulmonary disease (COPD) — is now available in the UK
PJ 2006;277:599
Full Text
|
| R&D news
600 Anticoagulant
drug-antidote combination safe for human use A novel approach
to anticoagulation, using an RNA aptamer-antidote combination, is
safe for use in humans, say US researchers
PJ 2006;277:600
Full Text
600 Viable male
contraceptive delivered to testes Viable male contraceptive
pills may be closer to human trials following the successful development
of a system to deliver a promising candidate drug direct to the testes
PJ 2006;277:600
Full Text
600 Platelet growth factor
helps hepatitis C patients start therapy A drug that improves platelet counts may allow patients with hepatitis C and thrombocytopenia to benefit from antiviral therapy
PJ 2006;277:600
Full Text
600 Oral vasopressin receptor
antagonist improves serum sodium in hyponatraemia Tolvaptan, an orally active vasopressin V2-receptor antagonist, is an effective treatment of hyponatraemia, new research shows. The drug promotes aquaresis — excretion of electrolyte-free water
PJ 2006;277:600
Full Text
600 Diabetes treatment
promise from human stem cells Stem cells derived from human bone marrow
enhance the repair of insulin-producing beta-islet cells in the pancreases of
diabetic mice, a study shows
PJ 2006;277:600
Full Text
600 Vaccine against S
aureus Scientists have created a vaccine against Staphylococcus
aureus
PJ 2006;277:600
Full Text |
The
Pharmaceutical Journal